Acetic Acid → 4-methanesulfonyloxy-5-methoxy-7-{1-(tert-butoxycarbonyl)-5-[N-(2-hydroxyethyl)-N-ethylaminomethyl]indol-2-yl}isoindolinone

HRID 21289

Reaktionsgleichung

Reaktionsgleichung von HRID 21289
[CH3:1][S:2]([O:5][C:6]1[C:14]([O:15][CH3:16])=[CH:13][C:12]([C:17]2[N:18]([C:28]([O:30][C:31]([CH3:34])([CH3:33])[CH3:32])=[O:29])[C:19]3[C:24]([CH:25]=2)=[CH:23][C:22](C=O)=[CH:21][CH:20]=3)=[C:11]2[C:7]=1[CH2:8][NH:9][C:10]2=[O:35])(=[O:4])=[O:3].[CH2:36]([NH:38][CH2:39][CH2:40][OH:41])[CH3:37].[C:42](O)(=O)C.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>C(#N)C>[CH3:1][S:2]([O:5][C:6]1[C:14]([O:15][CH3:16])=[CH:13][C:12]([C:17]2[N:18]([C:28]([O:30][C:31]([CH3:34])([CH3:32])[CH3:33])=[O:29])[C:19]3[C:24]([CH:25]=2)=[CH:23][C:22]([CH2:42][N:38]([CH2:39][CH2:40][OH:41])[CH2:36][CH3:37])=[CH:21][CH:20]=3)=[C:11]2[C:7]=1[CH2:8][NH:9][C:10]2=[O:35])(=[O:3])=[O:4]

Komponenten

6

Versuchsvorschrift

In a similar manner to Step 2 of Example 6, 4-methanesulfonyloxy-5-methoxy-7-[1-(tert-butoxycarbonyl)-5-formylindol-2-yl]isoindolinone (100 mg, 0.200 mmol) was dissolved in acetonitrile (5.8 mL), and the solution was treated with 2-(ethylamino)ethanol (0.195 mL, 2.00 mmol), acetic acid (0.229 mL, 4.00 mmol) and sodium triacetoxyborohydride (212 mg, 1.00 mmol), followed by purification by preparative thin-layer chromatography (chloroform/methanol=4/1) to obtain 4-methanesulfonyloxy-5-methoxy-7-{1-(tert-butoxycarbonyl)-5-[N-(2-hydroxyethyl)-N-ethylaminomethyl]indol-2-yl}isoindolinone (68.3 mg, yield 60%).

Aufarbeitung

  1. customfollowed by purification by preparative thin-layer chromatography (chloroform/methanol=4/1)

Quellen und Nachweise

ORD-Eintrag
ord-eb553b135f62461c895c93c70d8e265d
Quelldatensatz
uspto-grants-2010_06
Patentnummer
US07745641B2

Verknüpfte Notizen

Wird geladen…